Company / Working Capital
AMICUS THERAPEUTICS, INC. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$438.3M
FY2025
5-year range
$284.8M / $450.9M
FY2021-FY2025
Trend
+23.1%
vs FY2024
Sector context
#100 of 213
Health Care
What the data says
At $438M, AMICUS THERAPEUTICS, INC.'s working capital ranks #100 of 213 in the Health Care sector. Working Capital has increased for 3 consecutive years, from $285M in FY2022 to $438M in FY2025.
Based on SEC 10-K filings.
$438M in FY2025 with a 5-year CAGR of -0.5%.
Improved from $315M to $438M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +15.5%
- 5-Year CAGR
- -0.5%
- 10-Year CAGR
- -
Sector benchmark
#100 of 213 in Health CareTop 47% of 213This company $438.3M Sector average $934.6M
▼
-53.1% below sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s working capital has grown for 3 consecutive years.
- 5-year CAGR of -0.5%, indicating a declining trend.
- In FY2025, working capital increased 23.1% year-over-year.
- Ranks #100 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $438.3M | +23.1% |
| FY2024 | $356.0M | +12.9% |
| FY2023 | $315.4M | +10.7% |
| FY2022 | $284.8M | -36.8% |
| FY2021 | $450.9M | +0.2% |
| FY2020 | $449.8M | +15.0% |
| FY2019 | $391.3M | -15.9% |
| FY2018 | $465.0M | +44.4% |
| FY2017 | $321.9M | +40.5% |
| FY2016 | $229.1M | +60.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026